---
category: news
title: "InSilicoTrials, Axoltis partner to work on potential ALS therapy"
excerpt: "Axoltis Pharma is joining InSilicoTrials to advance the development of NX210c, its lead candidate for neurodegenerative diseases like ALS."
publishedDateTime: 2023-07-28T17:37:00Z
originalUrl: "https://alsnewstoday.com/news/potential-als-therapy-nx210c-be-tested-insilico-axoltis-teamup/"
webUrl: "https://alsnewstoday.com/news/potential-als-therapy-nx210c-be-tested-insilico-axoltis-teamup/"
type: article
quality: 19
heat: 19
published: false

provider:
  name: ALS News Today
  domain: alsnewstoday.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Axoltis teaming with InSilicoTrials on MS candidate NX210c"
    excerpt: "The companies will use InSilicoTrials' simulation platform to assess NX210c's effectiveness with MS, other neurodegenerative disorders."
    publishedDateTime: 2023-07-31T12:53:00Z
    webUrl: "https://multiplesclerosisnewstoday.com/news-posts/2023/07/31/axoltis-teaming-with-insilicotrials-ms-candidate-nx210c/"
    type: article
    provider:
      name: Multiple Sclerosis News Today
      domain: multiplesclerosisnewstoday.com
    quality: 4

secured: "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;eQ4nv9DDv2LDLbGd254UPg=="
---

